Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.37 EUR | -0.54% |
|
-8.02% | -56.82% |
07-03 | Top Decliners | MT |
07-03 | UBS Adjusts Price Target on Walgreens Boots Alliance to $12 From $17, Maintains Neutral Rating | MT |
Strengths
- The stock, which is currently worth 2024 to 0.12 times its sales, is clearly overvalued in comparison with peers.
- The company appears to be poorly valued given its net asset value.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- This company will be of major interest to investors in search of a high dividend stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Sector: Drug Retailers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-56.82% | 9.72B | - | ||
-45.52% | 8.7B | B | ||
-24.76% | 6.57B | B | ||
-5.95% | 6.09B | C+ | ||
+91.60% | 5.11B | C | ||
-3.50% | 4.58B | D- | ||
+1.56% | 4.32B | B | ||
-27.53% | 4.03B | C | ||
+2.28% | 2.96B | B | ||
-20.90% | 2.51B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- WBA Stock
- W8A Stock
- Ratings Walgreens Boots Alliance, Inc.